Trial ID or NCT#

NCT04292730

Status

recruiting iconRECRUITING

Purpose

The primary objective of this study was to evaluate the efficacy of 2 remdesivir (RDV) regimens compared to standard of care (SOC), with respect to clinical status assessed by a 7-point ordinal scale on Day 11.

Official Title

A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate COVID-19 Compared to Standard of Care Treatment

Eligibility Criteria

Ages Eligible for Study: Older than 12 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Aruna Subramanian
Aruna Subramanian
Infectious disease doctor
Clinical Professor, Medicine - Infectious Diseases

Contact us to find out if this trial is right for you.

CONTACT

SPECTRUM